NASDAQ$BTTC

Black Titan Corp · Q1 2024 earnings

Q1 2024 earnings · · Investor relations

Headline financials

Total Revenue

$328.00

Previous: $98K-99.7%
EPS (adj)

-$1.24

Previous: -$2.20+43.6%
Capital Expenditures

$0.00

No prior period
Free Cash Flow

-$613K

No prior period
Net Income

-$314K

Previous: -$1.65M+81.0%
Operating Income

-$314K

Previous: -$1.7M+81.5%
Gross Profit

$328.00

Previous: $55K-99.4%
Cash & Equivalents

$6.16M

Previous: $1.14M+442.2%
Total Assets

$6.65M

Previous: $2.17M+206.5%
R&D Expense

$0.00

No prior period

Revenue & EPS history

Titan Pharmaceuticals · Revenue · Quarterly

$328

Q1 2024-99.7%vs Q1 2023
Beat estimate in 0 of 3 quarters(0%)
ActualEstimate

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro